Rise in Unwanted Pregnancies to Spur Contraceptives Market, Poised to Register Downturn due to COVID-19 Pandemic
Most unwanted pregnancies occur among adolescents and young women. Such pregnancies are a major source of the prevalence of sexually transmitted diseases (STDs) such as HIV, chlamydia, genital herpes and hepatitis B. With this ever-increasing risk, there is a rise in awareness about modern contraceptives. Governments across the world have heavily invested in family planning and sex education programs to spread awareness about the dangers of STDs.
On the back of these trends, the global contraceptives market is set to receive an uptick in the near future. A robust 6.4% CAGR is predicted for the contraceptives market during the forecast period (2020-2025). The market shall surpass a valuation of US$ 37,242.7 Mn by the end of 2025. Other trends, notably the introduction of new, innovative and low cost contraceptive devices by key market players is also expected to significantly leverage the contraceptives market. For instance, Agile Therapeutics is performing a stage 3 trial for Twirla, a contraceptive patch designed to deliver a low daily dose of estrogen.
The COVID-19 pandemic is poised to bring about a downturn in the sales of contraceptives, owing to social distancing and limited physical contact among young people. The global supply of external physical barriers such as condoms shall experience a drop, owing to tighter border restrictions regarding import and export of products and reduced production.
Contraceptive Devices to Acquire Maximum Market Share
The contraceptive devices segment shall contribute to the maximum growth of the contraceptives market. Contraceptive devices are projected to capture more than half of the global contraceptives market during the forecast period. This is attributed to the major side effects of ingesting contraceptive drugs, particularly among women. These include nausea, headache, weight gain, increased bleeding, dysmenorrhea and menstrual changes. Moreover, the introduction of custom-fit condoms by key market players is expected to burgeon the segment’s market share. Projected CAGR for the contraceptive devices segment is pegged at 6.6% during the forecast period.
To access our cutting edge insights, request for a report sample here
North America to Remain Kingpin, Asia-Pacific Expanding Healthily
North America is anticipated to dominate the contraceptives market, in the wake of growing prevalence of unintended pregnancies, rising demand for reversible contraceptives and public sector initiatives to provide funding for family planning and contraception. The region is expected to surpass a valuation of US$ 12,987.4 by 2025. Projected CAGR for the same is pegged at 6.6% during the forecast period.
Asia-Pacific is emerging as a burgeoning market for contraceptives. High incidence of the spread of STDs due to a rapidly expanding population is a key motivator for the expansion of the contraceptives market. Realizing this, governments across the region have initiated awareness campaigns on contraceptives in rural and urban areas. The contraceptives market in the Asia-Pacific is projected to surpass a value of US$ 7,925.7 by the end of 2025, expanding at a CAGR of 6.8%.
For more regional insights on the contraceptives market, ask an analyst here
Product Research & Development Key Growth Levers of Companies
The global contraceptives market is highly fragmented. Major market players such as Allergen, plc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Bayer AG and Janssen Pharmaceutical Company account for half of the total market share. The companies primarily concentrate on product launches in order to broaden their market footprint. Pfizer Inc’s Sayana Press, for instance, is the first injectable contraceptive for women available in the U.K. The company is also in the process of conducting a study evaluating levonorgestrel and ethinyl estradiol as potential oral contraceptives.
Merck & Co, Inc., offers contraceptive care in the form of combined oral pills, vaginal rings, intrauterine devices and sub-dermal implants. Popular products include Cyclessa, Desogen, NuvaRing, Implanon and Nexplanon. Another important player, Cipla, manufactures oral contraceptives named Crisanta. The medicine contains Drospirenone which prevents the fertilization of the egg with the sperm. It also induces hormonal changes contributing to the prevention of pregnancy.
COVID-19 Market Insights:
The outbreak of the novel coronavirus respiratory disease, or COVID-19, has affected millions globally. As the risk of infections grows exponentially, countries are taking heavy precautionary measures to contain the spread of the deadly virus. With people practicing social distancing, physical contact of any kind, be it handshakes, hugs, kisses or sexual intercourse has been significantly restricted. This is anticipated to significantly impact the sales of contraceptive devices during the forecast period. Physical barriers, especially condoms, are anticipated to witness a downturn, owing to shutting down of several production units. In Asia, several Chinese factories were shuttered when the pandemic initially broke out and workers were forced to stay home in order to contain the spread of the infection. Since most condom manufacturers are situated in Asia, the global supply of the physical contraceptive barrier shall be disrupted.
The closing of international borders in the wake of the pandemic has limited delivery flows of contraceptives, essential maternal health medicines and antiretroviral drugs. Fortunately, the healthcare industry has recognized this and key players are bolstering efforts to stave off the negative impact of supply-chain disruptions in the global contraceptives market. The UN Population Fund (UNFPA), in its interim technical brief in March 2020, advocated governments to promote public and private partnership to mobilize the private sector to enhance supplies of sanitary items and medical equipment and redouble efforts to ensure the procurement, provision, appropriate administration and in-country distribution of required sexual and reproductive health products (SRH), continue investing in reproductive and sexual health supply chain and protective clothing for clinical management of COVID-19.
Global Contraceptives Market- Scope of the Report
The recent study by Fact.MR on global contraceptives market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of the global contraceptives market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the manufacturing of contraceptive devices. The study also provides dynamics that are responsible for influencing the future status of the global contraceptives market over the forecast period.
A detailed assessment of global contraceptives market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global contraceptives market along with their product portfolio enhances the reliability of this comprehensive research study.
Global Contraceptives Market: Report Summary
The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in global contraceptives market across the globe.
A comprehensive estimate on global contraceptives market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of global contraceptives market during the forecast period. Price point comparison by region with global average price is also considered in the study.
Global Contraceptives Market Segmentation
Fact.MR has studied the global contraceptives market with detailed segmentation on the basis product type, distribution channel and key regions.
|
Product Type |
Distribution Channel |
Key Regions |
|
Contraceptive drugs (hormonal): Oral Contraceptives: Combined Contraceptives Mini pills Contraceptive Injectable Topical Contraceptive Patch |
Hospital Pharmacy: Public Private |
North America |
|
Contraceptive Devices: Male Contraceptive Devices Female Contraceptive Devices: Female Condoms Contraceptive Diaphragms Contraceptive Sponges Contraceptive Vaginal Rings Intrauterine Devices Sub-dermal Contraceptive Implants Non-surgical Permanent Contraception Devices |
Independent Pharmacy |
Europe |
|
|
Online Platform |
Asia Pacific |
|
|
Clinics |
Latin America |
|
|
Others |
Middle East & Africa |
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”
Global Contraceptives Market: Analysis on Market Size Evaluation
Global contraceptives market has been analyzed for each market segment, in terms of value (US$ Mn).
Market estimates at global and regional levels for contraceptives is available in terms of “US$ Mn” for value, along with market attractiveness evaluation in the report. A Y-o-Y growth contrast on prominent contraceptive devices segments, along with market attractiveness evaluation has been incorporated in the report.
Global Contraceptives Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the global contraceptives report, which have helped to deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of global contraceptives market during the forecast period.
Country-specific valuation on demand for assistive devices has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. Detailed breakup in terms of value for emerging countries has also been included in the report.
Global Contraceptives Market: In-depth Analysis on Competitive Landscape
The report sheds light on the leading manufacturers of contraceptives along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of contraceptives, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in global contraceptives market. Prominent manufacturers with established market presence in global contraceptives market are Allergen, plc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Bayer AG and Janssen Pharmaceutical Company.
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Contraceptive Market Size (US$ Mn) and Forecast, by Region, 2020 and 2025
3.2. Global Contraceptive Market: Market Snapshot
4. Market Overview
4.1. Global Contraceptive Market Overview
4.2. Global Contraceptive Market Key Industry Developments
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Key Trends
5.6. Global Contraceptive Market Revenue Projections (US$ Mn), 2020–2025
5.7. Regulatory Framework
5.8. Heat Map Analysis - Company
6. Global Contraceptive Market Analysis, by Product
6.1. Introduction
6.2. Key Insights
6.3. Global Contraceptive Market Size and Forecast, by Product
6.3.1. Contraceptive Drugs
6.3.1.1. Oral Contraceptives
6.3.1.1.1. Combined Contraceptives
6.3.1.1.2. Mini-pills
6.3.1.2. Contraceptive Injectable
6.3.1.3. Topical Contraceptive Patch
6.3.2. Contraceptive Injectable
6.3.2.1. Male Contraceptive Devices
6.3.2.2. Female Contraceptive Devices
6.3.2.2.1. Female Condoms
6.3.2.2.2. Contraceptive Diaphragms
6.3.2.2.3. Contraceptive Sponges
6.3.2.2.4. Contraceptive Vaginal Rings
6.3.2.2.5. Intrauterine Devices
6.3.2.2.6. Sub-dermal Contraceptives Implants
6.3.2.2.7. Non-Surgical Permanent Contraception Devices
6.4. Global Contraceptive Market Analysis, by Product
6.5. Global Contraceptive Market Attractiveness Analysis, by Product
7. Global Contraceptive Market Analysis, by Distribution Channel
7.1. Introduction
7.2. Key Insights
7.3. Global Contraceptive Market Size and Forecast, by Distribution Channel
7.3.1. Hospital Pharmacy
7.3.1.1. Public
7.3.1.2. Private
7.3.2. Independent Pharmacy
7.3.3. Online Platform
7.3.4. Clinics
7.3.5. Others
7.4. Global Contraceptive Market Analysis, by Distribution Channel
7.5. Global Contraceptive Market Attractiveness Analysis, by Distribution Channel
8. Global Contraceptive Market Analysis, by Region
8.1. Introduction
8.2. Key Insights
8.3. Global Contraceptive Market Size and Forecast , by Region, 2014–2025
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
8.4. Global Contraceptive Market Analysis, by Region
8.5. Global Contraceptive Market Attractiveness Analysis, by Region
9. North America Contraceptive Market Analysis
9.1. North America Contraceptive Market Key Findings
9.2. North America Contraceptive Market Overview
9.3. North America Contraceptive Market Size and Forecast, by Product
9.3.1. Contraceptive Drugs
9.3.1.1. Oral Contraceptives
9.3.1.1.1. Combined Contraceptives
9.3.1.1.2. Mini-pills
9.3.1.2. Contraceptive Injectable
9.3.1.3. Topical Contraceptive Patch
9.3.2. Contraceptive Injectable
9.3.2.1. Male Contraceptive Devices
9.3.2.2. Female Contraceptive Devices
9.3.2.2.1. Female Condoms
9.3.2.2.2. Contraceptive Diaphragms
9.3.2.2.3. Contraceptive Sponges
9.3.2.2.4. Contraceptive Vaginal Rings
9.3.2.2.5. Intrauterine Devices
9.3.2.2.6. Sub-dermal Contraceptives Implants
9.3.3. Non-Surgical Permanent Contraception Devices
9.4. North America Contraceptive Market Size and Forecast, by Distribution Channel
9.4.1. Hospital Pharmacy
9.4.1.1. Public
9.4.1.2. Private
9.4.2. Independent Pharmacy
9.4.3. Online Platform
9.4.4. Clinics
9.4.5. Others
9.5. North America Contraceptive Market Forecast, by Country
9.5.1. U.S.
9.5.2. Canada
9.6. North America Contraceptive Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Distribution Channel
9.6.3. By Country
10. Europe Contraceptive Market Analysis
10.1. Europe Contraceptive Market Key Findings
10.2. Europe Contraceptive Market Overview
10.3. Europe Contraceptive Market Size and Forecast, by Product
10.3.1. Contraceptive Drugs
10.3.1.1. Oral Contraceptives
10.3.1.1.1. Combined Contraceptives
10.3.1.1.2. Mini-pills
10.3.1.2. Contraceptive Injectable
10.3.1.3. Topical Contraceptive Patch
10.3.2. Contraceptive Injectable
10.3.2.1. Male Contraceptive Devices
10.3.2.2. Female Contraceptive Devices
10.3.2.2.1. Female Condoms
10.3.2.2.2. Contraceptive Diaphragms
10.3.2.2.3. Contraceptive Sponges
10.3.2.2.4. Contraceptive Vaginal Rings
10.3.2.2.5. Intrauterine Devices
10.3.2.2.6. Sub-dermal Contraceptives Implants
10.3.3. Non-Surgical Permanent Contraception Devices
10.4. Europe Contraceptive Market Size and Forecast, by Distribution Channel
10.4.1. Hospital Pharmacy
10.4.1.1. Public
10.4.1.2. Private
10.4.2. Independent Pharmacy
10.4.3. Online Platform
10.4.4. Clinics
10.4.5. Others
10.5. Europe Contraceptive Market Forecast, by Country
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Rest of Europe
10.6. Europe Contraceptive Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Distribution Channel
10.6.3. By Country
11. Asia Pacific Contraceptive Market Analysis
11.1. Asia Pacific Contraceptive Market Key Findings
11.2. Asia Pacific Contraceptive Market Overview
11.3. Asia Pacific Cytometry Market Size and Forecast, by Product
11.3.1. Contraceptive Drugs
11.3.1.1. Oral Contraceptives
11.3.1.1.1. Combined Contraceptives
11.3.1.1.2. Mini-pills
11.3.1.2. Contraceptive Injectable
11.3.1.3. Topical Contraceptive Patch
11.3.2. Contraceptive Injectable
11.3.2.1. Male Contraceptive Devices
11.3.2.2. Female Contraceptive Devices
11.3.2.2.1. Female Condoms
11.3.2.2.2. Contraceptive Diaphragms
11.3.2.2.3. Contraceptive Sponges
11.3.2.2.4. Contraceptive Vaginal Rings
11.3.2.2.5. Intrauterine Devices
11.3.2.2.6. Sub-dermal Contraceptives Implants
11.3.3. Non-Surgical Permanent Contraception Devices
11.4. Asia Pacific Contraceptive Market Size and Forecast, by Distribution Channel
11.4.1. Hospital Pharmacy
11.4.1.1. Public
11.4.1.2. Private
11.4.2. Independent Pharmacy
11.4.3. Online Platform
11.4.4. Clinics
11.4.5. Others
11.5. Asia Pacific Contraceptive Market Forecast, by Country
11.5.1. China
11.5.2. India
11.5.3. Japan
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Asia Pacific Contraceptive Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Distribution Channel
11.6.3. By Country
12. Latin America Contraceptive Market Analysis
12.1. Latin America Contraceptive Market Key Findings
12.2. Latin America Contraceptive Market Overview
12.3. Latin America Cytometry Market Size and Forecast, by Product
12.3.1. Contraceptive Drugs
12.3.1.1. Oral Contraceptives
12.3.1.1.1. Combined Contraceptives
12.3.1.1.2. Mini-pills
12.3.1.2. Contraceptive Injectable
12.3.1.3. Topical Contraceptive Patch
12.3.2. Contraceptive Injectable
12.3.2.1. Male Contraceptive Devices
12.3.2.2. Female Contraceptive Devices
12.3.2.2.1. Female Condoms
12.3.2.2.2. Contraceptive Diaphragms
12.3.2.2.3. Contraceptive Sponges
12.3.2.2.4. Contraceptive Vaginal Rings
12.3.2.2.5. Intrauterine Devices
12.3.2.2.6. Sub-dermal Contraceptives Implants
12.3.3. Non-Surgical Permanent Contraception Devices
12.4. Latin America Contraceptive Market Size and Forecast, by Distribution Channel
12.4.1. Hospital Pharmacy
12.4.1.1. Public
12.4.1.2. Private
12.4.2. Independent Pharmacy
12.4.3. Online Platform
12.4.4. Clinics
12.4.5. Others
12.5. Latin America Contraceptive Market Forecast, by Country
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Latin America Contraceptive Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Distribution Channel
12.6.3. By Country
13. Middle East & Africa Contraceptive Market Analysis
13.1. Middle East & Africa Contraceptive Market Key Findings
13.2. Middle East & Africa Contraceptive Market Overview
13.3. Middle East & Africa Cytometry Market Size and Forecast, by Product
13.3.1. Contraceptive Drugs
13.3.1.1. Oral Contraceptives
13.3.1.1.1. Combined Contraceptives
13.3.1.1.2. Mini-pills
13.3.1.2. Contraceptive Injectable
13.3.1.3. Topical Contraceptive Patch
13.3.2. Contraceptive Injectable
13.3.2.1. Male Contraceptive Devices
13.3.2.2. Female Contraceptive Devices
13.3.2.2.1. Female Condoms
13.3.2.2.2. Contraceptive Diaphragms
13.3.2.2.3. Contraceptive Sponges
13.3.2.2.4. Contraceptive Vaginal Rings
13.3.2.2.5. Intrauterine Devices
13.3.2.2.6. Sub-dermal Contraceptives Implants
13.3.3. Non-Surgical Permanent Contraception Devices
13.4. Middle East & Africa Contraceptive Market Size and Forecast, by Distribution Channel
13.4.1. Hospital Pharmacy
13.4.1.1. Public
13.4.1.2. Private
13.4.2. Independent Pharmacy
13.4.3. Online Platform
13.4.4. Clinics
13.4.5. Others
13.5. Middle East Contraceptive Market Forecast, by Country
13.5.1. South Africa
13.5.2. Saudi Arabia
13.5.3. U.A.E.
13.5.4. Rest of Middle East & Africa
13.6. Middle East Contraceptive Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Distribution Channel
13.6.3. By Country
14. Competition Landscape
14.1. Global Contraceptive Market Share Analysis, by Company (2018)
14.2. Company Profiles
14.2.1. Merck & Co., Inc.
14.2.1.1. Overview (HQ, Employee Strength, Business Segments)
14.2.1.2. Financials
14.2.1.3. Recent Developments
14.2.1.4. Strategy
14.2.2. Cipla Inc.
14.2.2.1. Overview (HQ, Employee Strength, Business Segments)
14.2.2.2. Financials
14.2.2.3. Recent Developments
14.2.2.4. Strategy
14.2.3. Allergan plc
14.2.3.1. Overview (HQ, Employee Strength, Business Segments)
14.2.3.2. Financials
14.2.3.3. Recent Developments
14.2.3.4. Strategy
14.2.4. Bayer AG
14.2.4.1. Overview (HQ, Employee Strength, Business Segments)
14.2.4.2. Financials
14.2.4.3. Recent Developments
14.2.4.4. Strategy
14.2.5. HLL Lifecare Limited
14.2.5.1. Overview (HQ, Employee Strength, Business Segments)
14.2.5.2. Financials
14.2.5.3. Recent Developments
14.2.5.4. Strategy
14.2.6. Mankind Pharma
14.2.6.1. Overview (HQ, Employee Strength, Business Segments)
14.2.6.2. Financials
14.2.6.3. Recent Developments
14.2.6.4. Strategy
14.2.7. Pfizer, Inc.
14.2.7.1. Overview (HQ, Employee Strength, Business Segments)
14.2.7.2. Financials
14.2.7.3. Recent Developments
14.2.7.4. Strategy
14.2.8. Teva Pharmaceutical Industries Ltd l
14.2.8.1. Overview (HQ, Employee Strength, Business Segments)
14.2.8.2. Financials
14.2.8.3. Recent Developments
14.2.8.4. Strategy
14.2.9. Mithra Pharmaceuticals
14.2.9.1. Overview (HQ, Employee Strength, Business Segments)
14.2.9.2. Financials
14.2.9.3. Recent Developments
14.2.9.4. Strategy
14.2.10. Janssen Pharmaceutical Company
14.2.10.1. Overview (HQ, Employee Strength, Business Segments)
14.2.10.2. Financials
14.2.10.3. Recent Developments
14.2.10.4. Strategy
14.2.11. Reckitt Benckiser Group plc
14.2.11.1. Overview (HQ, Employee Strength, Business Segments)
14.2.11.2. Financials
14.2.11.3. Recent Developments
14.2.11.4. Strategy
Fact.MR offers custom research services that help clients to get specific research solutions
Related reports
We are committed towards customer satisfaction and quality service.
Our Clients
Contraceptives Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025